These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 10530557

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Pathologic features of breast cancers in women with previous benign breast disease.
    Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ.
    Am J Clin Pathol; 2001 Mar; 115(3):362-9. PubMed ID: 11242792
    [Abstract] [Full Text] [Related]

  • 23. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma.
    Renshaw AA, Cartagena N, Derhagopian RP, Gould EW.
    Am J Clin Pathol; 2002 May; 117(5):797-9. PubMed ID: 12090431
    [Abstract] [Full Text] [Related]

  • 24. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
    Sullivan PS, Apple SK.
    Breast J; 2009 May; 15(2):146-54. PubMed ID: 19292800
    [Abstract] [Full Text] [Related]

  • 25. Immunohistochemistry increases the accuracy of diagnosis of benign papillary lesions in breast core needle biopsy specimens.
    Shah VI, Flowers CI, Douglas-Jones AG, Dallimore NS, Rashid M.
    Histopathology; 2006 May; 48(6):683-91. PubMed ID: 16681684
    [Abstract] [Full Text] [Related]

  • 26. Effect of core-needle biopsy vs fine-needle aspiration on pathologic measurement of tumor size in breast cancer.
    Yang JH, Lee WS, Kim SW, Woo SU, Kim JH, Nam SJ.
    Arch Surg; 2005 Feb; 140(2):125-8. PubMed ID: 15723992
    [Abstract] [Full Text] [Related]

  • 27. Fibroepithelial lesions with cellular stroma on breast core needle biopsy: are there predictors of outcome on surgical excision?
    Jacobs TW, Chen YY, Guinee DG, Holden JA, Cha I, Bauermeister DE, Hashimoto B, Wolverton D, Hartzog G.
    Am J Clin Pathol; 2005 Sep; 124(3):342-54. PubMed ID: 16191502
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
    Sinha PS, Bendall S, Bates T.
    Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.
    Ariga R, Zarif A, Korasick J, Reddy V, Siziopikou K, Gattuso P.
    Breast J; 2005 Dec; 11(4):278-80. PubMed ID: 15982396
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.